Tumorend

Early stage biotech developing complex carbohydrate vascular disruptors as oncology therapeutics

placeBaton Rouge, Louisiana, United States calendar_todayFounded 2009 language tumorend.com

Innovation

1 patent family (1 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 64 times.

YearFilings
20161
20171
20191
20211
20221
20251

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon